657—37.2 (124) Definitions. As used in this chapter:
“Board” means the Iowa board of pharmacy.
“Controlled substance” means a drug, substance, or immediate precursor in Schedules I through V set forth in Iowa Code chapter 124, division II.
“Council” means the PMP advisory council established pursuant to Iowa Code section 124.555 to provide oversight and to co-manage PMP activities with the board.
“Database information”  or “PMP information”  means information submitted to and maintained by the PMP database.
“DEA number” means the registration number issued to an individual or pharmacy by the U.S. Department of Justice, Drug Enforcement Administration authorizing the individual or pharmacy to engage in the prescribing, dispensing, distributing, or procuring of a controlled substance.
“Dispenser” means a person who delivers to the ultimate user a substance required to be reported to the PMP database. “Dispenser” does not include a person exempt from reporting pursuant to subrule 37.3(1).
“Health care professional” means a person who, by education, training, certification, or licensure, is qualified to provide and is engaged in providing health care to patients. “Health care professional” does not include clerical or administrative staff. “Health care professional,” other than a licensed prescriber or pharmacist, may include, but is not limited to, a certified pharmacy technician or a technician trainee, a nurse, or a medical assistant or supervised trainee such as a pharmacist-intern or student, a medical student, or a nursing student.
“National drug code”  or “NDC number”  means the universal product identifier used in the United States to identify a specific human drug product.
“Patient” means the person or animal that is the ultimate user of a drug for whom a prescription is issued or for whom a drug is dispensed.
“Patient's agent” means a person legally authorized to make health care decisions or gain access to health care records on behalf of the patient for purposes of directing the patient’s care.
“Patients rights committee”  or “committee”  means the physician and pharmacist members of the council responsible for monitoring and ensuring protection and preservation of patients’ rights as provided in Iowa Code section 124.555(3)“e.”
“PMP administrator” means the board staff person or persons designated to manage the PMP under the direction and oversight of the board and the council.
“Practitioner” means a prescriber or a pharmacist.
“Practitioner’s agent” means a health care professional who is employed by or under the direct supervision of a health care practitioner and who is authorized by the practitioner to access PMP information as provided in subrule 37.4(1).
“Prescriber” means a licensed health care professional with the authority to prescribe prescription drugs including controlled substances.
“Prescription monitoring program”  or “PMP”  means the program established pursuant to these rules for the collection and maintenance of PMP information and for the provision of PMP information to authorized individuals, including health care providers, for use in treatment of their patients.
“Prescription monitoring program database”  or “PMP database”  means a centralized database of reportable controlled substance prescriptions dispensed to patients and includes data access logs, security tracking information, and records of each individual who requests PMP information.
“Reportable prescription” means the record of a Schedule II, III, or IV controlled substance dispensed by a pharmacy to a patient pursuant to a prescriber-authorized prescription. “Reportable prescription” does not include those records excluded in subrule 37.3(1).
“Schedule II, III, and IV controlled substances” means those substances that are identified and listed as Schedule II, III, or IV substances in Iowa Code sections 124.205 through 124.210 or in the federal Controlled Substances Act (21 U.S.C. Section 812).
[ARC 7903B, IAB 7/1/09, effective 8/5/09; ARC 0056C, IAB 4/4/12, effective 7/1/12]